The list below contains all FTC press releases related to competition in the health care industry from 1995 to the present. Many of the current press releases contain links to the supporting case documents such as complaint filings and consent orders.

2009

• For Release: July 16, 2009
  FTC Testifies on Importance of Competition and Antitrust Enforcement to Lower-Cost, Higher-Quality Health Care
  The Federal Trade Commission today told the Senate Subcommittee on Consumer Protection, Product Safety, and Insurance of the Committee on Commerce, Science & Transportation that competition and the agency’s antitrust enforcement improves health care in the United States in two ways – first, by preventing or stopping anticompetitive agreements to raise prices and second, by helping to spur innovation that improves care and expands consumer access.
  
  
• For Release: June 24, 2009
  FTC Issues Interim Report on "Authorized Generic" Drugs
  The Federal Trade Commission today issued "Authorized Generics: An Interim Report," which presents the first set of results from a study conducted to examine the short-term and long-term effects of “authorized generics” on competition in the prescription drug marketplace.
  
  
• For Release: June 23, 2009
  FTC Chairman Leibowitz: Eliminating “Pay-for-Delay” Pharmaceutical Settlements Would Save Consumers $3.5 Billion Annually
  In a speech today before the Center for American Progress in Washington, D.C., Federal Trade Commission Chairman Jon Leibowitz said that an internal FTC analysis projects that stopping collusive “pay-for-delay” settlements between brand and generic pharmaceutical firms would save consumers $3.5 billion a year and also reap significant savings for the federal government, which pays approximately one-third of all prescription drug costs.
  
  
• For Release: June 11, 2009
  FTC Testifies on "Competition Issues and Follow-on Biologic Drugs"
  Hearing Concerns Release of Agency Report Summarizing Public Roundtable Findings

• For Release: June 10, 2009
  FTC Releases Report on “Follow-on Biologic Drug Competition”
  Providing FDA With Authority to Approve Follow-on Biologics Would be an Efficient Way to Bring Them to Market, Lowering Consumers’ Health Care Costs

• For Release: May 27, 2009
  FTC Authorizes Suit To Stop CSL’s Proposed $3.1 Billion Acquisition of Talecris Biotherapeutics
  The Federal Trade Commission has authorized a lawsuit to block CSL Limited’s proposed $3.1 billion acquisition of Talecris Biotherapeutics Holdings Corporation, charging that the deal would be illegal and would substantially reduce competition in the U.S. markets for four plasma-derivative protein therapies – Immune globulin (Ig), Albumin, Rho-D, and Alpha-1.
  
  
• For Release: April 14, 2009
  FTC Staff Advises Maryland Physician-Hospital Organization That it Will Not Recommend Antitrust Challenge to Proposal to Provide Member Physicians’ Services Through “Clinical Integration” Program
  The Federal Trade Commission’s Bureau of Competition has advised TriState Health Partners, Inc. (TriState), a physician-hospital organization based in Hagerstown, Maryland, that staff has no present intention to recommend that the Commission challenge the organization’s proposed clinical integration program, which would include joint contracting by its members with health plans and self-insured employers.
  
  
• For Your Information: April 3, 2009
  FTC Staff Comment Says New York Bill to Regulate Pharmacy Benefit Managers May Increase Pharmaceutical Prices for New York Consumers; Commission Approves Final Consent Order in Matter of Dow Chemical Company and Rohm & Haas Company
  Federal Trade Commission staff filed a comment stating that provisions of New York State Senate Bill 58 would likely have the unintended consequence of increasing prices that New York consumers and health plans pay for prescription drugs. The Commission has approved a final consent order in the matter of Dow Chemical Company and Rohm & Haas Company.
  
  
• For Release: March 31, 2009
  Bristol-Myers Squibb to Pay $2.1 Million Penalty for Failure to Disclose Agreement Involving Substantial Payments to Delay Entry of a Generic Version of the Drug Plavix
  Drug maker Bristol-Myers Squibb Company (BMS) will pay $2.1 million – the largest fine allowed by law – for failing to inform the Federal Trade Commission of agreements reached with Apotex, Inc., regarding potential generic competition to its blockbuster drug Plavix.
  
  
• For Release: March 31, 2009
  FTC Testifies in Support of Bill Banning “Pay-for-Delay” Settlements Between Brand and Generic Drug Companies
  Congressional Action Necessary to Prevent Higher Pharmaceutical Costs to Consumers and Federal, State, and Local Governments
  
  
• For Your Information: March 20, 2009
  FTC Staff Comment Says Bills to Authorize Collective Bargaining by Minnesota Health Care Cooperatives will Raise Health Care Costs for Minnesota Consumers
  According to the staff of the Federal Trade Commission, legislation pending before the Minnesota legislature that seeks to exempt certain activities by Minnesota health care cooperatives from federal and state antitrust law likely would raise health care costs and reduce insurance coverage for Minnesota consumers.
  
  
• For Your Information: February 3, 2009
  Commission Approves Final Consent Order in Matter of AllCare IPA; FTC Approves Final Consent Order in Matter of King Pharmaceuticals/Alpharma Inc.
  Following a public comment period, the Commission has approved a final consent order in the matter of AllCare IPA and in the matter of King Pharmaceuticals/Alpharma Inc.
  
  
• For Release: February 2, 2009
  FTC Sues Drug Companies for Unlawfully Conspiring to Delay the Sale of Generic AndroGel Until 2015
  The Federal Trade Commission has filed a complaint in federal district court challenging agreements in which Solvay Pharmaceuticals, Inc. paid generic drug makers Watson Pharmaceuticals, Inc. and Par Pharmaceutical Companies, Inc. to delay generic competition to Solvay’s branded testosterone-replacement drug AndroGel, a prescription pharmaceutical with annual sales of more than $400 million.
  
  
• For Release: January 29, 2009
  FTC Intervenes in Getinge AB’s Acquisition of Datascope Corporation
  Consent Order Requires Datascope to Divest Endoscopic Vessel Harvesting Assets

2008

• For Release: December 29, 2008
  FTC Intervenes in King Pharmaceuticals’ Acquisition of Rival Alpharma Inc.
  King Required to Divest Painkiller Kadian to Actavis to Restore Competition
  
  
• For Release: December 24, 2008
  FTC Settles Price-Fixing Charges Against Two Separate Doctors' Groups
  Physicians in Modesto, California and Boulder, Colorado Required to Modify Behavior to Protect Competition
  
  
• For Release: December 19, 2008
  FTC Intervenes in Teva Pharmaceutical Industries' Proposed $8.9 Billion Acquisition of Barr Pharmaceuticals
  Consent Order Requires Divestitures in Twenty-Nine U.S. Generic Drug Markets
  
  
• For Release: December 16, 2008
  FTC Sues Ovation Pharmaceuticals for Illegally Acquiring Drug Used to Treat Premature Babies with Life-Threatening Heart Condition
  Unlawful Acquisition Resulted in Nearly 1,300 Percent Price Hike; Agency Asks Court to Require Company to Give Up Unlawful Profits
  
  
• For Release: November 18, 2008
  Commission Announces Agenda for Roundtable on Follow-on Biologic Drugs
  Public Roundtable to be Held in Washington, DC, on November 21, 2008
  
  
• For Your Information: October 21, 2008
  Commission Approves Final Consent Order in Matter of Fresenius Medical Care AG & Co. KGaA/Daiichi Sankyo Company, Ltd.
  Following a public comment period, the Commission has approved a final consent order in the matter concerning Fresenius Medical Care AG & Co. KGaA/Daiichi Sankyo Company, Ltd.
  
  
• For Your Information: September 19, 2008
  FTC Extends Public Comment Period Related to Used Car Rule Review; Commission Approves Final Consent Order in Matter of Sun Pharmaceuticals and Taro Pharmaceuticals;
  FTC Approves Final Consent Order in Matter of Carlyle Group Partners IV, L.P.
  Commission approval of public comment period extension – The Commission has approved the publication of a Federal Register notice extending the pubic comment period related to the current regulatory review of the Used Motor Vehicle Trade Regulation Rule (Used Car Rule) through November 19, 2008.
  
  
• For Release: September 15, 2008
  FTC Challenges Vertical Agreement Between Fresenius and Daiichi Sankyo
  Commission Order Prevents Fresenius From Inflating Medicare Reimbursement Rates for Dialysis Drug
  
  
• For Release: August 27, 2008
  FTC Announces Workshop and Roundtable on Emerging Health Care Competition and Consumer Protection Issues
  Events to be Held in Washington, DC, This Fall; Public Comments Solicited
  
  
• For Release: August 13, 2008
  FTC Challenges Sun Pharmaceuticals’ Purchase of Taro Pharmaceutical Industries
  Consent Order Requires Sun to Sell Rights and Assets for Three Generic Drugs
  
  
• For Your Information: June 17, 2008
  FTC Approves Order Dismissing Administrative Complaint Against Inova Health System Foundation and Prince William Health System, Inc.
  Commission approval of order dismissing administrative complaint – The Commission has approved an order dismissing its administrative complaint against Inova Health System Foundation (Inova) and Prince William Health System, Inc. (PWHS) without prejudice, as the respondents publicly announced their mutual decision to terminate the proposed acquisition agreement.
  
  
• For Release: June 6, 2008
  Statement of FTC’s Bureau of Competition regarding Inova Health System’s Announced Withdrawal of Plans to Merge with Prince William Health System
  After a thorough investigation, the FTC filed a complaint in the U.S. District Court for the Eastern District of Virginia on May 12, 2008, seeking an injunction to stop the proposed combination of Inova and Prince William hospitals.
  
  
• For Your Information: June 3, 2008
  FTC Approves Filing of Staff Comments Regarding Proposed Regulation of Retail Health Care Facilities in Illinois
  Commission approval of filing of staff comments – The Commission has approved the filing of comments by the staff of the Office of Policy Planning and the Bureaus of Economics, Competition, and Consumer Protection with State Representative Elaine Nekritz, of the Illinois House of Representatives, regarding Illinois House Bill 5372 (HB 5372) and the proposed regulation of retail health care facilities (retail clinics) within the state.
  
  
• For Release: May 21, 2008
  FTC’s Bureau of Competition Issues FY 2007 Summary of Pharmaceutical Company Settlement Agreements
  Nearly Half Involved Payment to Generic Firms, Restricted Generics’ Ability to Enter the Market
  
  
• For Release: May 16, 2008
  U.S. Court of Appeals Affirms FTC Decision That Texas Doctors’ Group Engaged in Illegal, Anticompetitive Price-Fixing
  In a unanimous opinion issued on May 14, the U.S. Court of Appeals for the Fifth Circuit affirmed a 2005 Federal Trade Commission decision that found certain activities of North Texas Specialty Physicians (NTSP) violated Section 5 of the FTC Act.
  
  
• For Release: May 13, 2008
  FTC and Virginia AG File Complaint in Federal Court Seeking to Block Inova Health System Foundation’s Acquisition of Prince William Health System
  FTC and State Seek Temporary Restraining Order and Preliminary Injunction
  
  
• For Release: May 9, 2008
  FTC and Virginia Attorney General Seek to Block Inova Health System Foundation’s Acquisition of Prince William Health System
  Transaction Would Reduce Competition and Result in Higher Health Care Prices in Northern Virginia
  
  
• For Your Information: May 9, 2008
  FTC Designates Commissioner J. Thomas Rosch as ALJ in Case Challenging Inova Health System Foundation’s Acquisition of Prince William Health System, Inc.
  The Federal Trade Commission has designated Commissioner J. Thomas Rosch as the Administrative Law Judge (ALJ) in the administrative trial on the merits challenging the proposed acquisition by Inova Health System Foundation of Prince William Health System, Inc.
  
  
• For Release: April 28, 2008
  FTC Issues Final Opinion and Order to Restore the Competition Lost in Evanston Northwestern Healthcare Corporation’s Acquisition of Highland Park Hospital
  The Federal Trade Commission today issued its final opinion and order to restore the competition that was lost when Evanston Northwestern Healthcare Corporation (ENH) in suburban Chicago, Illinois, acquired its competitor, Highland Park Hospital.
  
  
• For Release: April 17, 2008
  FTC Submits Testimony to Florida State Senate Regarding Bill That Would Amend State’s Certificate of Need Laws
  At the request of Florida Governor Charlie Crist, the Federal Trade Commission has submitted written testimony on health care competition, Florida’s certificate of need (CON) laws, and Florida Senate Bill 2326 (S.B. 2326) to the Florida Governor and State Senate.
  
  
• For Your Information: April 15, 2008
  Commission Approves Final Consent Order in Matter of Connecticut Chiropractic AssociationCommission approval of final consent order - Following a public comment period, the Commission has approved the issuance of a final consent order in the matter concerning the Connecticut Chiropractic Association (CCA), the Connecticut Chiropractic Council (CCC), and Robert L. Hirtle (CCA’s legal counsel).
  
  
• For Release: March 17, 2008
  Federal Trade Commission to Host Workshop on Health Care Clinical Integration
  One-Day Public Event Scheduled for May 29, 2008, in Washington, DC
  
  
• For Release: March 10, 2008
  FTC to Host Workshop on Innovations in Health Care Delivery
  The Federal Trade Commission will host a workshop on April 24, 2008, to examine recent trends related to health care delivery.
  
  
• For Release: March 5, 2008
  FTC Challenges Illegal Boycott of Health Plan by Connecticut Chiropractors
  Chiropractors Must Modify Behavior to Protect Competition
  
  
• For Your Information: February 19, 2008
  FTC Submits Testimony to Alaska House of Representatives Regarding Bill That Would Amend State’s Certificate of Need Laws
  At the request of Governor Sarah Palin and the Alaska Department of Health and Social Services, the Federal Trade Commission has submitted written testimony to the Standing Committee on Health, Education, and Social Services of the state’s House of Representatives concerning health care competition, Alaska’s certificate of need (CON) laws, and House Bill 337 (H.B. 337), which would modify or repeal certain aspects of the state’s CON requirements.
  
  
• For Your Information: February 15, 2008
  FTC Staff Submits Comments on Establishing Collective Bargaining for Independent Home Care Providers in Ohio
  Commission approval of staff comments: At his request, staff of the FTC’s Office of Policy Planning, Bureau of Competition, and Bureau of Economics have submitted comments to Ohio State Senator William J. Seitz regarding Ohio Executive Order 2007 – 23S, issued by Governor Ted Strickland in July 2007 and entitled “Establishing Collective Bargaining for Home Health Care Workers.”
  
  
• For Your Information: February 14, 2008
  FTC Staff Issues Advisory Opinion to Kaiser Foundation Health Plan, Inc., Concerning Non-Profit Institutions Act
  Staff advisory opinion concerning Non-Profit Institutions Act: The staff of the Bureau of Competition has advised Kaiser Foundation Health Plan, Inc. that, in the staff’s opinion, Kaiser’s purchase and use of discounted pharmaceuticals in connection with a proposed program to provide health care services to persons covered under health benefits plans offered by self-insured employers falls within the Non-Profit Institutions Act (NPIA) exemption to the Robinson-Patman Act.
  
  
• For Release: February 13, 2008
  FTC Sues Cephalon, Inc. for Unlawfully Blocking Sale of Lower-Cost Generic Versions of Branded Drug Until 2012
  Complaint Charges Company Paid Four Generic Drug Makers in Order to Protect Monopoly Profits on its Leading Product
  
  
• For Your Information: February 1, 2008
  Commission Staff Files Comments with Puerto Rico’s Treasury and Financial Affairs Commission on Health Care Collective Bargaining Bill
  Commission approval of staff comments: The FTC’s Office of Policy Planning, Bureau of Competition, and Bureau of Economics have submitted comments to Antonio Silva Delgado of the Treasury and Financial Affairs Commission of the Puerto Rico House of Representatives regarding Senate Bill (S.B.) 2190, which would permit collective bargaining on fees and other matters for diverse individuals and corporate health care providers in Puerto Rico.

2007

• For Your Information: December 21, 2007
  Commission Announces Issuance of Information Requests to Generic and Authorized Generic Drug Companies; FTC Approves Proposed Divestiture in Matter of SCI and Alderwoods Group; Commission Approves Proposed Divestiture in Matter of Kyphon, Inc.
  Commission issuance of information requests: The Commission has issued information requests to generic and authorized generic drug manufacturers and marketers as part of its ongoing study of the short- and long-term effects of authorized generics on pharmaceutical drug competition. Commission approval of proposed divestitures: The Commission has approved a petition from Service Corporation International (SCI) and Alderwoods Group, Inc. seeking approval of a proposed divestiture related to SCI’s recent acquisition of Alderwoods. The Commission has approved a petition from Kyphon, Inc. regarding a proposed divestiture related to its recent acquisition of certain assets from Disc-O-Tech Medical Technologies, Ltd. and Discotech Orthopedic Technologies, Inc. (collectively Disc-O-Tech).
  

• For Release: December 10, 2007
  FTC Focuses Law Enforcement Lens on Unlawful Contact Lens Sales
  Two marketers of non-corrective, cosmetic contact lenses have agreed to settle Federal Trade Commission charges that they violated federal law by selling lenses without prescriptions.
  
  
• For Release: November 16, 2007
  FTC Challenges Schering-Plough’s Acquisition of Organon BioSciences
  N.V.Companies Required to Sell Rights and Assets Related to Three Poultry Vaccines to Wyeth
  
  
• For Your Information: November 6, 2007
  Commission Receives Petition to Reopen and Modify Order in Matter of Nine West Group; FTC Approves Final Consent Order in Matter of Merck KGaA and Mylan Laboratories
  Petition to reopen and modify order: The Commission has received a petition from Nine West Group, Inc. to reopen and modify a prior FTC order.; Commission approval of final consent order: Following a public comment period, the Commission has approved a final consent order in the matter concerning Merck KGaA and Mylan Laboratories, Inc.
  
  
• For Your Information: October 23, 2007
  FTC Approves Filing of Amended Complaint in Matter of Direct Marketing Concepts, Inc., et al.; Commission Approves Final Consent Order in Matter of Fresenius AG and American Renal Associates
  Commission approval of amended complaint filing: The Commission has approved the filing of an amended complaint in the matter currently pending against Direct Marketing Concepts, Inc., et al. Commission approval of final consent order: Following a public comment period, the Commission has approved the issuance of a final consent order in the matter concerning Fresenius AG and American Renal Associates.
  
  
• For Release: October 18, 2007
  FTC Testifies on Community Pharmacy Fairness Act of 2007
  Giving Health Care Providers License to Engage in Price Fixing and Boycotts Would be ‘Costly Step Backward on the Path to a Better Health Care System’
  
  
• For Release: October 09, 2007
  FTC Challenges Kyphon’s Acquisition of Disc-O-Tech
  Companies Must Divest Disc-O-Tech’s Confidence Product Line
  
  
• For Your Information: October 2, 2007
  FTC Approves Filing of Staff Comments with Massachusetts Department of Public Health
  Commission approval of filing of staff comments: The Commission has approved the filing of comments by the staff of the Office of Policy Planning and the Bureaus of Economics, Competition, and Consumer Protection with the Massachusetts Department of Public Health (DPH) regarding proposed limited service clinic (LSC) regulations.
  
  
• For Release: September 27, 2007
  FTC Challenges Mylan’s Proposed Acquisition of Merck’s Generic Subsidiary
  Companies Required to Sell Assets Related to Five Generic Pharmaceuticals
  
  
• For Your Information: September 21, 2007
  FTC Staff Advises Rochester Physician Organization That It Will Not Recommend Antitrust Challenge to Proposal to Provide Member Physicians' Services Through "Clinical Integration" Program
  Program Would Involve Joint Negotiation of Contracts and Prices With Health Plans
  
  
• For Your Information: September 11, 2007
  Commission Approves Final Consent Orders in Matters of South Carolina State Board of Dentistry and Colegio de Optometras de Puerto Rico
  Commission approval of final consent orders: The Commission has approved a final consent order in the matter concerning the South Carolina State Board of Dentistry and approved letters to the commenters of record. The Commission has approved a final consent order in the matter of Colegio de Optometras de Puerto Rico.
  
  
• For Release: September 7, 2007
  FTC Challenges Illegal Agreement to Close, Acquire Dialysis Clinics
  Parties Prohibited from Entry Into Similar Agreements and Required to Provide Prior Notice of Future Acquisitions in Warwick and Cranston, Rhode Island
  
  
• For Release: August 6, 2007
  Commission Rules that Evanston Northwestern Healthcare Corp.’s Acquisition of Highland Park Hospital Was Anticompetitive
  Unanimous Order Requires ENH to Establish Two Separate and Independent Managed Care Organization Contract Negotiating Teams
  
  
• For Release: July 30, 2007
  FTC Charges Puerto Rico Optometrists’ Group, Two of its Leaders, With Orchestrating Price-Fixing Conspiracy
  Consent Order Bars Group’s Doctors from Jointly Negotiating Prices or Terms of Service
  
  
• For Release: June 20, 2007
  South Carolina Board of Dentistry Settles Charges That it Restrained Competition in the Provision of Preventive Care by Dental Hygienists
  FTC Complaint Alleged Conduct Limited Needy Children’s Access to Care
  
  
• For Release: June 4, 2007
  FTC Challenges Rite Aid’s Proposed $3.5 Billion Acquisition of Brooks and Eckerd Pharmacies from Canada’s Jean Coutu Group, Inc.
  Consent Order Requires Sale of Stores in 23 U.S. Markets to Protect Competition
  
  
• For Your information: May 22, 2007
  FTC Approves Final Consent Order in Matter of Actavis/Abrika
  Commission approval of final consent order: Following a public comment period, the Commission has approved a final consent order in the matter of Actavis Group hf. and Abrika Pharmaceuticals, Inc.
  
  
• For Release: May 2, 2007
  FTC Testifies Before U.S. Senate on Barriers to Entry of Generic Drugs
  H.R. 1902 Called a “Fundamentally Sound” Approach to Eliminating Anticompetitive Pharmaceutical Exclusion Payments
  
  
• For Release: April 16, 2007
  FTC Challenges Actavis Group's Proposed Acquisition of Abrika
  To Restore Competition, Actavis Must Divest Rights to Generic Isradipine Capsules
  
  
• For Release: February 15, 2007
  FTC Testifies on Patent Reform Recommendations
  The Federal Trade Commission told a subcommittee of the House Judiciary Committee today that patent policy stimulates innovation by providing an incentive to develop and commercialize inventions, but that invalid or questionable patents can increase costs and hinder competition.
  
  
• For Your Information: January 19, 2007
  Commission Approves Final Consent Order in Matter of Johnson & Johnson/Pfizer
  Following a public comment period, the Commission has approved the issuance of final consent order in the matter concerning Johnson & Johnson’s acquisition of Pfizer, Inc.’s Consumer Healthcare business.
  
  
• For Release: January 18, 2007
  FTC Challenges Hospira/Mayne Pharma Deal
  To Protect Competition, Companies Must Sell Assets for Five Generic Injectable Drugs
  
  
• For Release: January 17, 2007
  FTC Provides Senate Testimony on Anticompetitive Patent Settlements in the U.S. Pharmaceutical Industry
  FTC Study Shows Substantial Increase in Number of Settlements Involving a Payment to the Generic and a Restriction on Generic Entry
  
  
• For Release: January 17, 2007
  Bureau of Competition Issues FY 2006 Summary of Pharmaceutical Company Settlement Agreements
  Shows Substantial Increase in the Number of Settlements Involving a Payment to the Generic and a Restriction on Generic Entry

2006

• For Release: December 29, 2006
  FTC Charges Chicago-Area Doctor Groups With Price Fixing
  Physicians Required to Modify Behavior to Protect Competition

• For Release: December 12, 2006
  FTC Challenges Terms of Johnson & Johnson’s Proposed Acquisition of Pfizer’s Consumer Healthcare Business To Protect Competition
  Divestitures of OTC Zantac, Cortizone, Unisom, and Balmex Eliminate Anticompetitive Problems

• For Your Information: December 8, 2006
  FTC Approves Final Consent Order in Barr/Pliva Matter
  Following a public comment period, the Commission has approved the issuance of final consent order in the matter concerning Barr Pharmaceuticals, Inc.’s acquisition of PLIVA d.d.
  
  
• For Release: October 31, 2006
  FTC Challenges Terms of Watson Pharmaceuticals’ Acquisition of Andrx
  Companies Must Sell Overlapping Drug Lines to Gain FTC Approval
  
  
• For Release: October 24, 2006
  Court Enters Final Order Settling FTC’s Charges Against Warner Chilcott
  Terms Protect Consumers from Agreements Designed to Delay Generic Drug Launches
  
  
• For Release: October 23, 2006
  Consumers Win as FTC Action Results in Generic Ovcon Launch
  Commission Action Fosters Generic Drug Entry and Leads to Settlement of Charges Against Warner Chilcott
  
  
• For Release: October 20, 2006
  FTC Challenges Barr’s Proposed Acquisition of Pliva
  Required Divestitures in Generic Drug and Organ Preservation Solution Markets Protect Consumers and Competition
  
  
• For Release: October 17, 2006
  FTC Charges That Thermo Electron’s Acquisition of Fisher Scientific Would Lessen Competition in U.S. Market for Centrifugal Vacuum Evaporators
  Requires Thermo to Divest Fisher’s CVE Business to Maintain Competition
  
  
• For Your Information: October 6, 2006
  Staff Submits Comments on Pharmacy Benefit Managers to Virginia House of Delegates; Commission Approves Issuance of Strategic Plan for Fiscal Years 2006-2011; FTC Approves Final Consent Order in Matter of New Century Health Quality Alliance, Inc.
  The FTC has approved the filing of comments by the staffs of the Bureaus of Competition and Economics and the Office of Policy Planning with the Virginia House of Delegates on the subject of pharmacy benefit managers (PBMs). The Commission has approved the release of The Federal Trade Commission Strategic Plan for Fiscal Years 2006-2011, as required under the Government Performance and Results Act (GPRA) and through guidance issued by the Office of Management and Budget. Following a public comment period, the Commission has approved the issuance of a final consent order in the matter concerning New Century Health Quality Alliance, Inc. and Prime Care of Northeast Kansas, L.L.C., et al.
  
  
• For Release: September 6, 2006
  FTC Testifies on Competition in Group Health Care
  The Federal Trade Commission today told the Senate Judiciary Committee that the agency protects health care consumers from anti-competitive conduct by enforcing antitrust laws, and that the FTC is committed to working with physicians and other providers to give them guidance to avoid antitrust pitfalls as they respond to market challenges.
  
  
• For Release: August 24, 2006
  FTC Charges Physician Groups With Price Fixing
  Physicians Must Modify Behavior to Protect Competition
  
  
• For Your Information: July 5, 2006
  FTC Approves Final Consent Order in Matter of Fresenius and Renal Care
  Following a public comment period, the FTC has approved the issuance of a final consent order in the matter concerning Fresenius AG and Renal Care Group.
  
  
• For Your Information: June 20, 2006
  FTC Staff: Alpena, Michigan, Public Schools Planned Pharmaceutical Transfer Falls Within NPIA; Final Consent Order Approved in Nations Title Consumer Protection Matter
  
  
• For Your Information: May 19, 2006
  Commission Approves Divestiture in Matter of DaVita/Gambro; FTC Approves Petition for Sale of Meow Mix Company to Del Monte Corporation; Final Consent Order Approved in Matter of Dynamic Health of Florida
  The Commission has granted a petition from DaVita Inc. (DaVita) requesting approval of a proposed divestiture related to its recent acquisition of Gambro Healthcare (Gambro); Following a public comment period, the Commission has approved the issuance of a final consent order in the matter concerning Vineet K. Chhabra (also known as Vincent K. Chhabra) and his companies, Dynamic Health of Florida, LLC, and Chhabra Group, LLC.
  
  
• For Release: April 24, 2006
  Bureau of Competition Issues FY 2005 Summary of Pharmaceutical Company Settlement Agreements
  
  
• For Your Information: April 21, 2006
  Commission Approves Final Consent Order in Matter of Allergan/Inamed
  Following a public comment period, the Commission has approved the issuance of a final consent order in the matter concerning Allergan, Inc.’s acquisition of Inamed Corporation.
  
  
• For Release: March 30, 2006
  Maintaining Competition, FTC Allows Fresenius’ $3.5 Billion Deal to Buy Rival Dialysis Provider Renal Care Group
  Settlement Requires the Sale of 91 Dialysis Clinics and Interest in 12 More in 66 Areas Across the United States
  
  
• For Release: March 29, 2006
  FTC Proposes Study of Competitive Impacts of Authorized Generic Drugs
  
  
• For Release: March 28, 2006
  Hospitals’ Plan for Collective Bargaining of Physicians’ Fees Likely Would Violate Federal Laws, FTC Staff Says
  
  
• For Release: March 8, 2006
  Preserving Competition, FTC Requires Divestiture Before Allowing Allergan’s Acquisition of Inamed
  Consent Order Requires Allergan to Divest Future Botox Rival Reloxin in $3.2 Billion Deal
  
  
• For Your Information: March 7, 2006
  FTC Staff Files Comments on New Jersey’s Proposed Advertising Guideline 4; Commission Finalizes Teva/Ivax Consent Order
  The Commission has authorized the staffs of the Bureau of Consumer Protection, Bureau of Economics, and Office of Policy Planning to file a letter with the New Jersey Supreme Court Committee on Attorney Advertising regarding Proposed Advertising Guideline 4, which would place certain restrictions on the use by lawyers or law firms of endorsements or testimonials from clients.; Following a public comment period, the Commission has approved a final order related to Teva Pharmaceutical Industries Ltd.’s recent acquisition of Ivax Corporation
  
  
• For Release: February 13, 2006
  Texas Doctors' IPA Agrees to Settle Price Fixing Charges
  
  
• For Your Information: February 7, 2006
  Davita Inc. Submits Petition for Approval of Proposed Divestiture; FTC Submits Budget Request and Performance Plans to Congress
  The Commission has received a petition from DaVita Inc. (DaVita) requesting approval of a proposed divestiture related to its recent acquisition of Gambro Healthcare (Gambro).; The Commission has approved the following documents: 1) the FTC’s FY 2007 Budget Overview Statement; 2) the Government Performance and Results Act (GPRA) Performance Plans for FY 2006 and FY 2007; and 3) an Update of the President’s Management Agenda Exhibit; The Commission has approved the following documents: 1) the FTC’s FY 2007 Budget Overview Statement; 2) the Government Performance and Results Act (GPRA) Performance Plans for FY 2006 and FY 2007; and 3) an Update of the President’s Management Agenda Exhibit
  
  
• For Release: January 23, 2006
  Preserving Competition, FTC Requires Divestitures Before Allowing Teva’s $7.4 Billion Acquisition of IVAX
  Consent Order Requires Divestitures in 15 Generic Drug Markets

[Back to Top]

2005

• For Release: December 1, 2005
  Commission Finds That North Texas Specialty Physicians Illegally Fixed Prices
  Unanimous Order Bars Respondents from Engaging in Joint Price Negotiations

• For Your Information: November 18, 2005
  Announced Action for November 18, 2005
  Following a public comment period, the Commission has approved the issuance of a final consent order in the matter concerning DaVita, Inc. and Gambro AB.

• For Release: November 7, 2005
  FTC Sues to Stop Anticompetitive Agreement in U.S. Drug Industry
  Warner Chilcott/Barr Pact Deprives Consumers of Access to Generic Oral Contraceptive for Five Years

• For Release: October 21, 2005
  Administrative Law Judge Orders Evanston Northwestern Healthcare Corporation to Sell Highland Park Hospital
  In Initial Decision, Rules That ENH’s 2000 Acquisition of Highland Park
  "Substantially Lessened Competition" in the Market for Acute Care Inpatient Services

• For Release: October 4, 2005
  FTC Accepts Settlement to Remedy DaVita’s Acquisition of Rival Outpatient Dialysis Clinic Provider Gambro
  Under Consent Agreement, DaVita to Sell 69 Clinics in 35 Markets Across United States

• For Release: September 20, 2005
  Announced Action for September 20, 2005
  The Commission has approved a petition to reopen and modify a final order in the matter concerning White Sands Health Care System, L.L.C., Alamogordo Physician Cooperative, Inc., Dacite, Inc., and James R. Laurenza.

• For Release: September 6, 2005
  FTC Issues Report on PBM Ownership of Mail-Order Pharmacies
  Study Shows PBM Ownership Does Not Result in Higher Costs for Consumers

• For Your Information: August 19, 2005
  Announced Action for August 19, 2005
  The Commission approved an application for proposed divestiture by Cemex, S.A. de C.V. (Cemex) related to its recent acquisition of RMC Group PLC (RMC); The Commission has authorized the staff to file an amended complaint in the matter currently pending against Elite Designs, Inc. and Anthony Antonelli; The staff of the FTC’s Bureau of Competition has advised North Mississippi Health Services (NMHS) that its purchase of pharmaceuticals to be dispensed to patients treated at a non-profit clinic and at a non-profit hospice is covered by the Non-Profit Institutions Act (NPIA).

• For Release: August 5, 2005
  South Carolina Physician-hospital Organization Agrees To Settle Physician Price-fixing Charges

• For Release: July 19, 2005
  Protecting Competition, the Federal Trade Commission Approves Novartis AG’s Acquisition of Eon Labs
  Divestitures Required in U.S. Markets for Generic Pharmaceuticals

• For Your Information: July 5, 2005
  Announced Action for July 5, 2005
  Following a public comment period, the Commission has approved a final consent order in the matter concerning San Juan IPA, Inc.

• For Your Information: June 17, 2005
  Announced Actions for June 17, 2005
  The Commission has authorized the staff to file an amended complaint in the matter currently pending against Cleverlink Trading Limited, Real World Media, Brian D. Muir, Jesse Goldberg, and Caleb Wolf Wickman.; Commission approval of final consent order: Following a public comment period, the Commission approved the issuance of a final consent order in the matter concerning New Millennium Orthopedics, LLC, et al.

• For Release: May 24, 2005
  FTC Testifies on New Entry into Hospital Competition
  Competition Can Help Make Health Care More Affordable, But Cannot Transfer Resources to Those Who Do Not Have Them

• For Your Information: May 20, 2005
  Announced Actions for May 20, 2005
  The Commission has received a petition from the Dow Chemical Corporation (Dow) requesting approval of certain amendments to the “Ineos Agreement,” which is incorporated into the decision and order allowing the 2001 merger of Dow and Union Carbide. The Commission has approved a final consent order addressing only the claims relating to Count III of the Complaint in the matter concerning Evanston Northwestern Healthcare Corp., et al. The Commission’s Bureau of Consumer Protection has launched a new section on the FTC’s Web site devoted to Project Scofflaw, which tracks offenders that have violated prior Commission orders.

• For Release: May 19, 2005
  Northwest New Mexico Physicians Agree to Settle FTC Charges That They Fixed Prices

• For Release: May 2, 2005
  FTC Halts Physician Price-Fixing in Cincinnati Area

• For Release: April 22, 2005
  FTC Requests Re-Hearing in Schering-Plough Case
  
  
• For Your Information: April 22, 2005
  Announced Actions for April 22, 2005
  The Commission has authorized the staff to file an amended complaint in the case currently pending against CHK Trading Corp., et al. (CHK). The staff of the Bureau of Competition has advised Stevens Hospital, in Edmonds, Washington, that its purchase of pharmaceuticals to be dispensed to patients treated by its clinic physicians is covered by the Non-Profit Institutions Act (NPIA). The Commission has approved the publication of a Federal Register notice concerning a new FTC publication incorporating model forms and procedures for identity theft victims, as required by the Fair and Accurate Credit Transactions Act (FACTA).

• For Your Information: April 19. 2005
  Announced Actions for April 19, 2005
  The Commission has approved a petition from Aventis S.A. (Aventis), the successor company to Hoechst AG and Rhone-Poulenc S.A. (RP) (the respondents), to reopen and modify a final consent order regarding the 1999 merger of the two companies. Following a public comment period, the Commission has approved the issuance of a final consent order and letter to the commenter of record in the matter concerning Preferred Health Services, Inc.

• For Your Information: April 7, 2005
  Announced Action for April 7, 2005
  The Commission has authorized the submission of a response to the U.S. Food and Drug Administration (FDA) regarding a citizen petition filed with the FDA by IVAX Pharmaceuticals, Inc. (IVAX) on January 5, 2005.

• For Release: April 5, 2005
  Chicago-Area Physicians' Group Agrees Not to Fix Prices
  FTC Order Settles Charges Against ENH Doctors' Group; Hospital Merger Trial Continue

• For Your Information: March 14, 2005
  In Letter to Virginia State Delegate, FTC Staff Supports Continued Competition in the Provision of Optometric Care to State's Consumers
  Comment Addresses Three Bills Currently Pending in State Legislature

• For Your Information: March 11, 2005
  Federal Trade Commission Staff Cites Opposition to North Dakota PBM Bill
  HB 1332 Likely to Limit PBM’s Ability to Reduce the Cost of Prescription Drugs

• For Release: March 2, 2005
  South Carolina Doctors’ Group Barred from Fixing Prices
  Group’s Physician Members Make Up 70 Percent of Doctors Near Seneca, SC

• For Your Information: February 11, 2005
  Announced Action for February 11, 2005
  The Commission has authorized the staff to file a brief as amicus curiae in Teva Pharmaceuticals USA, Inc. v. Pfizer, Inc., Case No. 04-1186 (Fed. Cir.) in support of Teva’s petition for rehearing or rehearing en banc.

• For Your Information: February 4 2005
  Announced Action for February 4, 2005
  Following a public comment period, the Commission has approved a final consent order in the matter concerning Genzyme Corporation and ILEX Oncology, Inc.

• For Your Information: January 14, 2005
  Announced Actions for January 14, 2005

[Back to Top]

2004

• For Release: December 20, 2004
  Protecting Competition, FTC Clears Genzyme Corp.’s $1 Billion Acquisition of Ilex Oncology, Inc.
  Divestitures Required in the U.S. Market for Solid Organ Transplant Acute Therapy Drugs

• For Release: November 16, 2004
  Administrative Law Judge Upholds FTC Complaint Against North Texas Specialty Physicians
  Rules Doctors’ Group Engaged in “Contract, Combination, or Conspiracy to Fix Prices”

• For Your Information: October 5, 2004
  Announced Actions for October 5, 2004

• For Release: September 28, 2004
  New Mexico PHO, Physician Group, and Their Agent Settle FTC Price-Fixing Charges

• For Your Information: September 24, 2004
  Announced Actions for September 24, 2004

• For Release: September 10, 2004
  FTC Staff: California Bill May Raise Prices for Pharmaceuticals
  In response to a request from California Assembly Member Greg Aghazarian, FTC staff have commented on a bill (AB 1960) that requires pharmacy benefit managers ("PBMs") to disclose certain information to purchasers and prospective purchasers of their services, as well as to prescribers and consumers.
  
  
• For Release: August 12, 2004
  Generic Drug Marketers Settle FTC Charges
  Complaint Charges Unlawful Agreement Not to Compete Drove Up Prices for Over-the-Counter Children’s Ibuprofen; Companies to Give-Up Illegal Profit

• For Release: August 11, 2004
  Piedmont Health Alliance Settles FTC Price-fixing Charges

• For Release: August 9, 2005
  With Conditions, FTC Allows Cephalon’s Purchase of CIMA, Protecting Competition for Breakthrough Cancer Pain Drugs
  Consent Order Requires Cephalon to Grant Third-Party License to Sell Generic Actiq in U.S.

• For Your Information: August 6, 2004
  Announced Action for August 6, 2004

• For Release: July 30, 2004
  FTC Denies State Dental Board’s Dismissal Motion on State Action Grounds
  Commission Remands Case to Administrative Law Judge

• For Release: July 28, 2004
  Resolving Anticompetitive Concerns, FTC Clears Sanofi-Synthélabo’s Acquisition of Aventis
  Sanofi Required to Divest Arixtra®, Campto® Studies, and Royalty Rights to Sepracor’s Estorra®

• For Release: July 23, 2004
  FTC and DOJ Issue Report on Competition and Health Care
  Report Reviews the Role of Competition, Provides Recommendations to Improve the Balance Between Competition and Regulation in Health Care

• For Your Information: July 16, 2004
  Announced Action for July 16, 2004

• For Release: June 07, 2004
  New Mexico Physicians' Group Agrees to Settle FTC Price-Fixing Charges

• For Your Information: May 25, 2004
  Announced Actions for May 25, 2004
  The Commission has authorized the filing of a joint amicus brief with the Department of Justice in McMahon v. Advanced Title Services Company of West Virginia, a case before the West Virginia Supreme Court of Appeals.The Commission has advised Bristol-Myers Squibb (BMS) that its proposed settlement with Teva Pharmaceuticals USA, Inc., does not raise issues under Section 5 of the Federal Trade Commission Act.

• For Your Information: May 11, 2004
  Announced Action for May 11, 2004
  By a vote of 5-0, the Commission has approved a final consent order and authorized the staff to send letters to the commentors of record in the matter concerning California Pacific Medical Group, Inc, d/b/a Brown & Toland Medical Group The Commission has published transcripts of the three-day joint FTC/DOJ Workshop on Merger Enforcement held in Washington, DC, on February 17-19, 2004.

• For Your Information: April 12, 2004
  FTC Staff: Rhode Island Bills Would Raise Prices for Pharmaceuticals
  Bills Sound Good on Paper, But Likely Would Harm Consumers

• For Your Information: April 2, 2004
  Announced Actions for April 2, 2004
  The Commission has filed in Federal court its complaint, stipulation, and agreed-to judgment against RHI AG (RHI) to resolve charges that RHI violated various provisions of an FTC order issued in 2001. The Commission has authorized the staff to seek leave to file an amended complaint in the matter currently pending against A. Glenn Braswell, et al. The Commission has authorized the staff to file an amicus curiae brief in Teva Pharmaceuticals USA v. Pfizer, Inc., Case No. 04-1186.

• For Release: February 11, 2004
  FTC Closes Its Investigation Into Caremark Rx’s Proposed Acquisition of Advance PCS
  Transaction Involves Two U.S. Providers of Prescription Benefit Management Services

• For Release: February 10, 2004
  FTC Challenges Hospital Merger That Allegedly Led to Anticompetitive Price Increases

• For Release: February 9, 2004
  San Francisco’s Brown & Toland Medical Group Settles FTC Price Fixing Charges

• For Release: January 13, 2004
  FTC Closes its Investigation of Genzyme Corporation's 2001 Acquisition of Novazyme Pharmaceuticals, Inc.
  Separate Statements Issued by Chairman Muris, Commissioners Thompson and Jones Harbour

• For Your Information: January 13, 2004
  Announced Actions for January 13, 2004
  The Commission has approved a petition from Wright Medical Technology, Inc. (Wright) to reopen and modify a 1994 consent order that arose from Wright’s cash tender offer for all shares of common stock and outstanding convertible preferred stock of Orthomet, Inc.; Tthe Commission has approved a final consent order and letter to the commenter of record in the matter concerning Memorial Hermann Health Network Providers.; The Commission has approved the publication of a Federal Register notice concerning the FTC’s regulatory review schedule.

• For Your Information: January 9, 2004
  Announced Actions for January 9, 2004
  Staff of the Commission’s Bureau of Competition has issued an advisory opinion at the request of Dunlap Memorial Hospital (Dunlap) in Orrville, Ohio, addressing whether Dunlap’s provision of pharmaceuticals to the Viola Startzman Free Clinic (Free Clinic) would fall within the scope of the Non-Profit Institutions Act (NPIA). Following a public comment period, the Commission has approved a modified final consent order in the matter concerning DSM N.V./Roche Holding AG and Koninklijke DSM N.V., et al.

[Back to Top]

2003

• For Release: December 24, 2003
  FTC Charges Piedmont Health Alliance And 10 Physicians with Price Fixing
  Frye Regional Medical Center and Tenet Healthcare Corporation Settle FTC Charges About Their Role in Physician Price Fixing

• For Your Information: December 19, 2003
  Announced Action for December 19, 2003
  The Commission has approved the publication of a Federal Register notice regarding the ceiling on allowable charges for certain disclosures under the Fair Credit Reporting Act (FCRA).

• For Release: December 18, 2003
  Commission Rules Schering-Plough, Upsher, and AHP Illegally Delayed Entry of Lower-Cost Generic Drug

• For Release: November 25, 2003
  Texas Doctors’ Group Settles FTC Price-Fixing Charges

• For Your Information: November 18, 2003
  Announced Action for November 18, 2003
  Following a public comment period, the Commission has approved a final consent order in the matter concerning Surgical Specialists of Yakima, P.L.L.C.; Cascade Surgical Partners, P.S.; and Yakima Surgical Associates, Inc., P.S.

• For Release: September 24, 2003
  FTC Settles Price-Fixing Charges Against Washington Doctors’ Group and Two of its Members

• For Your Information: September 23, 2003
  Announced Action for September 23, 2003
  Issuance of staff advisory opinion: The staff of the FTC's Bureau of Competition has advised counsel for Bay Area Preferred Physicians (BAPP) that it does not presently intend to recommend law enforcement action if BAPP establishes a "messenger" arrangement to minimize the costs associated with contracting between physicians and health plans and other third-party payors.

• For Release: September 17, 2003
  FTC Charges North Texas Specialty Physicians with Price Fixing
  Agency Alleges Group Raised Cost of Health Care for Consumers in Fort Worth Area

• For Release: September 15, 2003
  FTC Charges South Carolina Board of Dentistry
  Agency Alleges Illegal Actions Deprived Children of Preventive Dental Care

• For Release: September 11, 2003
  Statement by Federal Trade Commission Chairman Timothy J. Muris on Generic Paxil Launch

• For Release: September 9, 2003
  FTC Settles Price-fixing Charges Against Large Physician-hospital Organization in South Georgia
  Conduct Allegedly Led to Higher Prices for Thousands of Consumers by Reducing Competition Among Physicians and Among Hospitals

• For Release: July 22, 2003
  FTC Settles Price-Fixing Charges Brought Against Baton Rouge Physician Groups and Their Agent

• For Release: July 18, 2003
  FTC Settles Price-Fixing Charges Against Physician-Hospital Network in Northeast Maine
  First FTC Action to Charge an Organization with Price-Fixing in the Provision of Hospital Services

• For Your Information: July 15, 2003
  Announced Actions for July 15, 2003
  Following a public comment period, the Commission has approved the issuance of two final consent orders in the matters concerning Anesthesia Service Medical Group, Inc. and Grossmont Anesthesia Medical Group, Inc.

• For Release: July 11, 2003
  Federal Trade Commission Settles Price-Fixing Charges Against Washington University Physician Network
  Non-profit Corporation Includes 900 Faculty, 600 Independent Physicians in St. Louis Area

• For Release: July 9, 2003
  FTC Charges San Francisco's Brown & Toland Medical Group with Price-Fixing

• For Release: June 17, 2003
  FTC Testifies on Consumer Access to Generic Pharmaceuticals
  2002 Commission Study of Generic Drug Entry Prior to Patent Expiration Presented

• For Release: June 9, 2003
  Texas Physicians' Group Agrees To Settle FTC Charges of Collective Bargaining
  Southwest Physician Associates Barred from Negotiating Fees on Behalf of its Members

• For Release: May 30, 2003
  Two San Diego County Anesthesiology Groups Agree to Settle FTC Charges of Fixing Prices
  Groups Will Not Enter Into Agreements to Jointly Set Fees or Establish Stipends

• For Release: April 14, 2003
  Pfizer, Pharmacia Will Divest Assets to Settle FTC Charges

• For Your Information: March 18, 2003
  Announced Actions for March 18, 2003
  Received a petition from Solvay S.A. (Solvay) to reopen and modify the Commission's hold separate order regarding Solvay's acquisition of Ausimont S.p.A.; Issuance of staff advisory opinions, in two separate letters, Arkansas Children's Hospital (ACH) in Little Rock, Arkansas, and Valley Baptist Medical Center (VBMC) in Harlingen, Texas.; Approved an application for a proposed divestiture pursuant to its consent agreement and order with Biovail Corporation (Biovail); Commission has authorized the staff to file a second amended complaint in the pending court matter regarding 1st Beneficial Credit Services, et al.; approved the issuance of a final consent order in the matter concerning Dainippon Ink and Chemicals, Inc.'s acquisition of certain assets of the Bayer Corporation.

• For Release: March 7, 2003
  FTC Charges Bristol-Myers Squibb with Pattern of Abusing Government Processes to Stifle Generic Drug Competition
  Alleged Illegal Conduct Involves Three Drugs; Includes Improper "Orange Book" Listings and Unlawful Agreements in Restraint of Trade

• For Release: February 7, 2003
  FTC Staff Issues Advisory Opinion Regarding Proposed Formation of Physicians' Healthcare Advocacy Group in Dayton, Ohio
  Proposed Dissemination of Information and Expression of Opinions on Matters of Public Interest Not Likely to Restrict Competition Among Physicians

• For Your Information: January 29, 2003
  Announced Action for January 29, 2003
  Filed an amicus brief in the U.S. District Court for the Eastern District of Pennsylvania regarding the pending patent litigation between SmithKline Beecham (now known as GlaxoSmithKline or GSK) and Apotex Corporation, Apotex, Inc. and Torpharm Inc. (Apotex) concerning GSK's antidepressant drug product, Paxil.

• For Release: January 28, 2003
  FTC/DOJ Hearings to Focus on Health Care And Competition Law and Policy
  
  
• For Your Information: January 27, 2006
  Announced Action for January 27, 2006
  FTC Staff Files Comment on California’s Confidentiality of Medical Information Act

[Back to Top]

2002

• For Release: December 20, 2002
  FTC Requires Divestitures in Connection with Baxter's Purchase of Wyeth's Generic Injectable Drug Business
  Consent Order Will Preserve Competition in Markets for Certain General Anesthetics, Neuromuscular Blocking Agents, Antiemetics, and New Injectable Iron Replacement Therapies
  
  
• For Release: October 21, 2002
  FTC Staff Opposes Ohio Bill To Allow Physician Collective Bargaining
  Proposed Legislation Likely to Increase Costs and Reduce Access to Care

• For Release: October 21, 2002
  Statement of Federal Trade Commission Chairman Timothy Muris on the FDA's Proposals to Improve Consumer Access To Lower-Cost Generic Drugs

• For Your Information: October 11, 2002
  Announced Actions for October 11, 2002
  Approved the issuance of final consent orders and responses to the commenters of record in the matters concerning Philips Electronics and Okie Corporation.; approved the issuance of a final consent order and response to the commenter of record in the matter concerning R.T. Welter and Associates, Inc.; R. Todd Welter; Consultants in Obstetrics and Gynecology, P.C.; Mid Town Obstetrics & Gynecology, P.C.; Mile High OB/GYN Associates, P.C.; The OB-GYN Associates, Professional Corporation; Rocky Mountain OB-GYN, P.C.; The Women's Health Group, P.C.; Cohen and Womack, M.D., P.C.; and Westside Women's Care, L.L.P. (collectively known as Professionals in Women's Care).

• For Your Information: October 4, 2002
  Announced Action for October 4, 2002
  Commission has approved the issuance of a modified final consent order in the matter concerning Biovail Corporation and its branded drug Tiazac.

• For Your Information: September 6, 2002
  Announced Action for September 6, 2002
  Following a public comment period, the Commission has approved a final consent order, without modifications, and a letter to the commenter of record in the matter concerning Immunex Corporation and Amgen Inc.

• For Release: August 28, 2002
  Federal Trade Commission Announces Formation of Merger Litigation Task Force

• For Release: August 20, 2002
  Dallas-Fort Worth-area Physicians Group Agrees to Settle
  FTC Charges of Restraining Prices for Physicians’ Services

• For Release: August 20, 2002
  Denver-Area Physician Practice Groups and Their Agent Agree to Settle FTC Charges of Fixing Fees
  Competing Physicians Used Agent to Negotiate Higher Fees with Payors

• For Your Information: August 20, 2002
  Announced Actions for August 20, 2002
  The Commission has approved the issuance of a final consent order in the matter concerning Biovail Corporation and Elan Corporation, plc, and authorized a response letter to be sent to the one commenter of record.

• For Release: July 12, 2002
  Resolving Anticompetitive Concerns, FTC Clears $16 Billion Acquisition of Immunex Corp. By Amgen Inc.
  Companies Required to Implement Divestiture and Licensing Remedies in Three Biopharmaceutical Markets

• For Release: July 2, 2002
  Administrative Law Judge Dismisses FTC Allegations of Anticompetitive Conduct by Schering-plough and Upsher-Smith
  Commission Had Alleged Illegal Payments Delayed Entry of Generic Drugs to U.S. Market

• For Your Information: June 4, 2002
  Announced Action for June 4, 2002
  Order on filing of initial decision: Administrative Law Judge D. Michael Chappell has issued an order extending until June 26, 2002, the deadline for filing the initial decision in the matter of Schering-Plough Corporation, Upsher-Smith Laboratories, and American Home Products Corporation.

• For Release: May 13, 2002
  Two Denver-area Physician Groups Agree To Settle FTC Charges of Fixing Fees
  Groups Used Non-Physician Agent to Negotiate Higher Fees with Payors

• For Release: April 23, 2002
  Wrongful "Orange Book" Listing Raises Red Flag with FTC; Leads to Consent Order with Biovail Corp. Concerning its Drug Tiazac
  Company also Allegedly Acquired Exclusive Patent License from DOV Illegally

• For Release: April 5, 2002
  Napa Valley OB/GYN Group Settles FTC Antitrust Charges
  For-Profit Corporation Allegedly Implemented Agreements to Fix Fees Among its Members

• For Release: March 25, 2002
  FTC Staff Opposes Alaska Physicians' Health Plan Legislation:
  Physician Collective Bargaining Would Significantly Increase Heath Care Costs

• For Your Information: February 21,  2002 
  Staff Advisory Opinion: MedSouth, Inc.
  

• For Release: February 19, 2002
  FTC Agreement with American Home Products Corp. Would Protect Consumers from Anticompetitive Practices
  Complaint Alleged Payments to AHP by Schering-Plough to Delay Entry of Generic K-Dur 20

• For Release: February 14, 2002
  FTC Staff Opposes Washington State Proposal to Allow Physician Collective Bargaining
  Proposed Legislation Significantly Would Increase Consumer Health Care Costs

• For Release: January 31, 2002
  FTC Staff Opposes Alaska Proposal to Allow Physician Collective Bargaining
  Proposed Legislation Would Significantly Increase Consumer Health Care Costs

• For Your Information: January 9, 2002
  Announced Actions for January 9, 2002
  Issuance of Two Amicus Curiae Memorandum of Law Briefs: Bristol-Myers-Squibb and Buspirone and The Hearst Trust and First Data Bank; publication of Federal Register notice regarding the Trade Regulation Rule on Power Output Claims for Amplifiers Used at Home.

[Back to Top]

2001

• For Release: December 20, 2001
  Non-profit Institutions Act Covers Pharmaceuticals Dispensed to Retired Employees, FTC Staff Advises

• For Release: December 14, 2001
  Hearst Corp. To Disgorge $19 Million and Divest Business to Facts and Comparisons to Settle FTC Complaint

• For Release: November 20, 2001
  Statement of Susan A. Creighton, Deputy Director, Bureau of Competition Regarding FTC Settlement with Hearst Corporation

• For Release: October 11, 2001
  The Hearst Corporation Settles Charges of Filing Incomplete Pre-merger Report
  Hearst to Pay Record Civil Penalty of $4 Million

• For Your Information: April 30, 2001
  Announced Actions for April 30, 2001
  Final approval of consent in Alaska Healthcare Network, Inc.; approval of extension of time period in the matter of Baxter International, Inc.; release of Commission report: The Twenty-third Annual Report to Congress Regarding the Hart-Scott-Rodino (HSR) Premerger Notification Program

• For Release: April 4, 2001
  FTC Charges Hearst Trust with Acquiring Monopoly in Vital Drug Information Market
  Commission Will Ask Court for Divestiture and Disgorgement of Illegal Profits

• For Release: April 2, 2001
  Consent Agreement Resolves Complaint Against Pharmaceutical Companies Hoechst Marion Roussel, Inc. and Andrx Corp.
  Commission Alleged that Companies' Agreement Likely to Stifle Competition in U.S. Drug Market

• For Release: April 2, 2001
  FTC Charges Schering-Plough over Allegedly Anticompetitive Agreements with Two Other Drug Manufacturers
  Complaint Alleges Illegal Payments to Delay Entry of Generic Products into the U.S. Market

• For Release: February 15, 2001
  FTC Dismisses Complaint Against California Dental Association

[Back to Top]

2000

• For Release: September 20, 2000
  Fairbanks, Alaska Physician's Group to Settle FTC Charges Price-Fixing and Concerted Refusals to Deal with Health Plans

• For Your Information: July 27, 2000
  Establishing Pharmacy Network as Proposed Not Likely to Restrain Competition, FTC Staff Advises

• For Release: July 12, 2000
  Statement of Richard G. Parker, Director, FTC Bureau of Competition
  FTC, 33 State Attorneys General, Mylan Laboritories, Inc. and Other Defendants Request Suspension of Pretrial Proceedings

• For Release: March 21, 2000
  Puerto Rico Dental Association Agrees to Settle FTC Charges of Price Fixing, Boycotting Providers, and Restraining Truthful Advertising by Members

• For Release: March 16, 2000
  FTC Charges Drug Manufacturers with Stifling Competition in Two Prescription Drug Markets
  Complaint Filed Against Hoechst Marion Roussel, Inc. and Andrx Corp.; Proposed Settlement Reached with Abbott Laboratories and Geneva Pharmaceuticals, Inc.Complaints Charge Multi-Million-Dollar Arrangements Were Designed to Keep Generic Versions of Cardizem CD and Hytrin Off the Market
  
  
• For Release: March 7, 2000
  Wisconsin Chiropractic Association and Its Director Agree to Settle FTC Charges of Price-Fixing;
  Related Settlement with Two La Crosse Chiropractors Resolving Allegations of Price-fixing and Organizing Boycott of Local Managed Care Plan

[Back to Top]

1999

• For Release: June 22, 1999
  FTC Chairman Tells House Judiciary Committee Doctor Collective Bargaining Bill Would Be Bad Medicine for Consumers

• For Your Information: May 20, 1999
  Announced Actions for May 20, 1999

• For Your Information: May 19, 1999
  Creation of Community Pharmacy Network as Proposed Not Likely to Restrain Competition, FTC Staff Advises

• For Your Information: May 4, 1999
  Announced Actions for May 4, 1999

• For Release: March 22, 1999
  Lake Tahoe Physician Group to Settle FTC Charges that They Conspired to Fix Prices and Limit Choice for Consumers

• For Your Information: March 15, 1999
  Announced Actions for March 15, 1999

• For Your Information: February 12, 1999
  Announced Actions for February 12, 1999

[Back to Top]

1998

• For Release: December 21, 1998
  Mylan, Nation’s Second Largest Generic Drug Maker, Charged with Restraint of Trade, Conspiracy & Monopolization
  Illegal Conduct Resulted in Price Increases of up to 3000 Percent for Two Anti-anxiety Drugs, FTC Alleges; Agency to Seek $120 Million in Consumer Refunds

• For Release: December 14, 1998
  Pharmacy Association in Puerto Rico and its Former President Agree to Settle Price Fixing Charges

• For Release: September 16, 1998
  Dentists in Puerto Rico Agree to Settle FTC Charges That They Conspired to Fix Prices and Engaged in an Illegal Boycott Denying Dental Care to Residents of Puerto Rico

• For Your Information: August 26, 1998
  Announced Action for August 26, 1998

• For Your Information: August 21, 1998
  Announced Actions for August 21, 1998

• For Release: August 20, 1998
  Merger of Only Two Hospitals in Poplar Bluff, Mo., Would Violate Antitrust Laws, FTC Charges

• For Your Information: August 13, 1998
  Associates in Neurology

• For Release: July 30, 1998
  FTC and State of Missouri Win Court Order Blocking Merger of Two Missouri Hospitals

• For Release: June 19, 1998
  Louisiana Group of Doctors to Settle FTC Charges That it Fixed Prices

• For Release: May 21, 1998
  Oregon Group of Institutional Pharmacies To Settle FTC Charges that It Fixed Prices

• For Your Information:May 20, 1998
  FTC Isssues Staff Advisory to Phoenix Medical Network, Inc.

• For Your Information: April 17, 1998
  Announced Actions for April 17, 1998 (Corrected Copy)

• For Release: April 16, 1998
  FTC and Missouri Attorney General Seek to Block Merger of the Only General Hospitals in Butler County, Missouri

• For Your Information: April 10, 1998
  Announced Actions for April 10, 1998

• For Release: February 19, 1998
  Colorado Physician Group To Settle FTC Charges that They Conspired To Raise Prices and Limit Choice for Consumers

• For Release: January 6, 1998
  Chicago-Area Doctors, Firms Settle FTC Charges over Fixing Prices for Kidney-Stone Treatment

[Back to Top]

1997

• For Release: October 2, 1997
  Puerto Rican Physicians Agree To Settle FTC Charges that they Conspired To Fix Prices and Engaged in an Illegal Boycott Denying Healthcare to Residents of Puerto Rico
  
  
• For Your Information: September 26, 1997
  Announced Action(s) for September 26,1997
  
  
• For Release: September 26, 1997
  FTC Ends Administrative Challenge To Hospital Merger In Grand Rapids, Michigan
  
  
• For Your Information: September 5, 1997
  Announced Actions for September 5, 1997
  
  
• For Your Information: August 28, 1997
  Announced Actions for August 28, 1997
  
  
• For Your Information: August 12, 1997
  New Jersey Pharmacists Association
  
  
• For Your Information: July 29, 1997
  Announced Actions for July 29, 1997
  
  
• For Your Information: July 18, 1997
  Announced Actions For July 18, 1997
  
  
• For Your Information: June 19, 1997
  First Look, L.L.C.
• For Your Information: June 13, 1997
  Announced Action(s) for June 13, 1997
  
  
• For Your Information: May 23, 1997
  Announced Action(s) for May 23,1997
  
  
• For Your Information: May 14, 1997
  Yellowstone Physicians, L.L.C.
  
  
• For Release: May 13, 1997
  FTC Charges Mesa County, Colorado Physician Group with Acting To Raise Prices, Reduce Competition
  
  
• For Your Information: April 18, 1997
  Staff Opinion--Foundation for the Accreditation of Hematopoietic Cell Therapy
  
  
• For Your Information: February 21, 1997
  Announced Actions for February 21, 1997
  
  
• For Your Information: January 31, 1997
  Mobile Health Resources, L.L.C.
  
  
• For Your Information: January 30, 1997
  Ohio Ambulance Network, Inc.
  
  
• For Your Information: January 29, 1997
  FTC Obtains Relief for Health Care Consumers in California County
  
  
• For Your Information: January 24, 1997
  Announced Actions for January 24, 1997

[Back to Top]

1996

• For Your Information: December 9, 1996
  FTC Staff Has Advised the Southwest Florida Oral Surgery Associates (SFOSA) Its Proposal To Form a "Cooperative" Does Not Appear To Violate the Antitrust Laws.
  
  
• For Release: November 18, 1996
  FTC To Appeal District Court Decision in Butterworth/Blodgett Hospital Merger Case
  
  
• For Your Information: November 13, 1996
  Announced Actions for November 13, 1996
  
  
• For Your Information: November 1, 1996
  Announced Actions for November 1, 1996
  
  
• For Your Information: October 24, 1996
  FTC Staff Issues Advisory Opinion that a Planned Survey of Hospital Prices in the Waco, Texas Area, Appears to Meet Guidelines Outlined in the Joint FTC/Department of Justice Statements of Antitrust Enforcement Policy in Health Care, Issued in August, 1996.
  
  
• For Release: October 23, 1996
  Montana Physicians Agree to Settle FTC Charges that they Conspired To Raise Prices and Limit Choices for Consumers
  
  
• For Your Information: October 11, 1996
  Announced Actions for October 11, 1996
  
  
• For Your Information: October 4, 1996
  Announced Actions for October 4, 1996
  
  
• For Your Information: August 30, 1996
  Announced Actions for August 30, 1996
  
  
• For Release: August 28, 1996
  Federal Trade Commission, Justice Department Revise Policy Statements on Health Care Antitrust Enforcement
  
  
• For Your Information: August 16, 1996
  Announced Actions for August 16, 1996
  
  
• For Your Information: August 2, 1996
  Announced Actions for August 2, 1996
  
  
• For Your Information: July 26, 1996
  Announced Actions for July 26, 1996
  
  
• For Release: July 19, 1996
  Mayo Medical Laboratories
  
  
• For Your Information: June 14, 1996
  Announced Actions for June 14, 1996
  
  
• For Your Information: June 7, 1996
  Announced Actions for June 7, 1996
  
  
• For Your Information: May 17, 1996
  Announced Actions for May 17, 1996
• 
  
• For Your Information: April 5, 1996
  American Medical Association
  
  
• For Release: March 26, 1996
  California Dental Association
  
  
• For Your Information: March 12, 1996
  More Announced Actions' for March 12, 1996
  
  
• For Release: February 27, 1996
  FTC's Pitofsky Outlines How Antitrust Enforcement can Adapt to Rapidly Changing Health Care Arena
  
  
• For Your Information: February 23, 1996
  Announced Actions for February 23, 1996
  
  
• For Your Information: February 2, 1996
  Annouced Actions for February 2, 1996
  
  
• For Your Information: February 1, 1996
  FTC Staff Have Advised a Group of New Orleans Urologists that Group's Plan to Establish a Urology Services Network Does Not Appear to Violate Antitrust Laws.
  
  
• For Release: January 19, 1996
  FTC Says Action to Block Merger of Grand Rapids Hospital will Help Keep Prices Competitive at all Area Hospitals.
  
  
• For Your Information: January 18, 1996
  FTC Has Approved the Application of Columbia/HCA Healthcare Corporation To Divest Its 84 Percent Partnership Interest in the Alaska Surgery Center in Anchorage, Alaska
  
  
• For Your Information: January 11, 1996
  Columbia/HCA Healthcare Corporation of Nashville, Tennessee, Has Petitioned FTC to Modify an Agreement
  
  
• For Release: January 3, 1996
  Robert F. Leibenluft Named to Head FTC Bureau of Competition, Health Care Shop.
  
  
• For Your Information: January 2, 1996
  HEALTHSOUTH Corporation, and its Subsidiary, ReLife of Tennessee, Inc., Have Applied for FTC Approval
  
  
• For Your Information: January 2, 1996
  Columbia/HCA Healthcare Corporation has Applied for FTC Approval

[Back to Top]

1995

• For Your Information: December 19, 1995
  Staff of FTC Have Advised Southern Arizona Therapy Network, Inc. that Plan To Establish a Network Does Not Appear To Violate the Antitrust Laws
  
  
• For Release: December 1, 1995
  FTC Ends Administrative Challenge of Hospital Merger in Joplin, Missouri
  
  
• For Your Information: November 30, 1995
  FTC Approves Consent Agreement with Columbia/HCA Healthcare Corp.
  
  
• For Your Information: November 14, 1995
  Columbia/HCA Healthcare Corporation Applies for Approval to Divest North Okaloosa Medical Center in Crestview, Florida.
  
  
• For Your Information: November 9, 1995
  FTC Staff Advises Columbine Family Health Center Proposed Cost-Sharing Agreement with Other Hospital Does Not Appear To Violate Anitrust Laws.
  
  
• For Your Information: November 1, 1995
  The American Dental Trade Association has petitioned FTC to Terminate1950 Consent Order...
  
  
• For Your Information: November 1, 1995
  FTC Grants Petition to Reopen and Set Aside California Medical Association (CMA) Consent Order...
  
  
• For Your Information: October 27, 1995
  Columbia/HCA Healthcare Corporation Applies for Approval...
  
  
• For Your Information: October 20, 1995
  Charter Medical Corporation Petitions To Reopen and Modify a 1995 Consent Order
  
  
• For Your Information: October 19, 1995
  Columbia/HCA Healthcare Corporation Has Applied for Approval To Divest Hospitals.
  
  
• For Your Information: October 5, 1995
  Columbia/HCA Healthcare Corporation Settles Charges
  
  
• For Your Information: October 4, 1995
  Local Health System, Inc., Blue Water Health Services Corp., and Mercy Health Services
  
  
• For Release: September 29, 1995
  FTC Staff Has Advised the Central Texas Medical Group (CTMG) that Its Proposed Method of Operating is Unlikely To Violate Federal Antitrust Laws.
  
  
• For Release: September 29, 1995
  FTC Staff Has Advised the Eastern Ohio Physicians Organization, Inc. (EOPO) that Its Proposed Method of Operating is Unlikely To Violate Federal Antitrust Laws.
  
  
• For Release: September 22, 1995
  Hematology/Oncology Care Specialists of Western Pennsylvania, P.C
  
  
• For Release: September 22, 1995
  Federal News Service Group, Inc.
  
  
• For Release: August 29, 1995
  Columbia/HCA Healthcare Corp.
  
  
• For Release: August 21, 1995
  Otolaryngology Specialty Providers of Georgia
  
  
• For Release: August 16, 1995
  Physicians Group, Inc.
  
  
• For Release: July 25, 1995
  California Dental Association
  
  
• For Release: July 13, 1995
  Northwestern Nevada Orthopaedic Surgery Alliance
  
  
• For Release: July 11. 1995
  Lee Memorial Hospital
  
  
• For Release: July 3, 1995
  Local Health System, Inc.
  
  
• For Release: June 30, 1995
  Columbia/HCA Healthcare Corporation
  
  
• For Release: June 21, 1995
  Elmore Community Hospital
  
  
• For Release: June 16, 1995
  California All Health
  
  
• For Release: June 12, 1995
  California Medical Association
  
  
• For Release: June 8, 1995
  Medical Association of Puerto Rico
  
  
• For Release: June 5, 1995
  Erlanger Medical Center
  
  
• For Release: May 15, 1995
  Columbia/HCA Healthcare Corporation (Correction)
  
  
• For Release: May 5, 1995
  American Academy of Orthopaedic Surgeons
  
  
• For Release: April 26, 1995
  Physicians Group, Inc.
  
  
• For Release: April 21, 1995
  Columbia/HCA Healthcare Corporation
  
  
• For Release: April 21, 1995
  Healthtrust, Inc.--The Hospital Company
  
  
• For Release: April 17, 1995
  HEALTHSOUTH Corporation
  
  
• For Release: April 3, 1995
  Oakland Physician Network

[Back to Top]

1993

• For Release: April 20, 1993
  Pennsylvania Pharmacy Bill